drugset / Trial / NCT06465641

Methylphenidate in KBG Syndrome: N-of-1 Series

NCT06465641

Phase 4 Recruiting 15 enrolled Radboud University Medical Center
RandomizedCrossoverQuadruple-blindTreatment

Summary

The goal of this clinical trial\] is to learn about the effect of methylphenidate in children and adolescents with KBG syndrome. The main question it aims to answer is: • What is the effectiveness of methylphenidate on attention deficit and ADHD-related symptoms in children and adolescents with KBG syndrome? Participants will receive multiple blocks of treatment with methylphenidate and placebo and fill out various questionnaires.

Timeline

Start
2024-11-13
Primary completion
2027-01-01
Completion
2027-10-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylphenidate Small molecule